持ち回り閣議でレムデシビル特例承認の政令改正決まる2020/5/2 17:32政治政策反応記事に戻る米製薬企業ギリアド・サイエンシズが開発した新型コロナの治療候補薬「レムデシビル」（ロイター）記事に戻る
/cloudfront-ap-northeast-1.images.arcpublishing.com/sankei/KDZ5VLWLGZIPPF4MGNESGUSZC4.jpg)
/cloudfront-ap-northeast-1.images.arcpublishing.com/sankei/FH3JD5NHEBISTDF5D4VL5T2QY4.jpg)
/cloudfront-ap-northeast-1.images.arcpublishing.com/sankei/VZR5722XURLPXJBMZHU7SXKLQY.jpg)
:quality(70)/cloudfront-ap-northeast-1.images.arcpublishing.com/sankei/55PKGYARXBN67HQKTMKCBU36GE.jpg)
:quality(70)/cloudfront-ap-northeast-1.images.arcpublishing.com/sankei/GJXNXZKZRVL57DSMQ5NUOV7VQM.jpg)
:quality(70)/cloudfront-ap-northeast-1.images.arcpublishing.com/sankei/FVAEM7A3EVIP3LNPHLMQ6ZCC34.jpg)